Thomas R. Kosten

Thomas R. Kosten Thomas R. Kosten

Professor of Psychiatry
Neuroscience, Pharmacology, and Immunology
Baylor College of Medicine
Houston, Texas

 
Biography

Following a successful 25-year tenure as Professor and Chief of Psychiatry at Yale University and Veteran Affairs Connecticut, Dr. Kosten joined the Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC) in July 2006, bringing over 30 years of exemplary Federal service, the majority of which has been with the Department of Veterans Affairs (VA). Over the period from 2006-2011, Dr. Kosten served as the Research Director of the VA National. With a joint appointment at Baylor College of Medicine (BCM), Dr. Kosten is the JH Waggoner Chair & Professor of Psychiatry, Pharmacology, Neuroscience and Immunology and Pathology. He is also vice-Chair for Psychiatry and Codirector of the Dan L. Duncan Institute for Clinical and Translational Research at Baylor College of Medicine. His other key appointments are Distinguished Professor of Psychiatry at Peking University Medical School and Professor of Epidemiology and of Behavioral Sciences at MD Anderson Cancer Prevention Center. He established the Division of Addictions Psychiatry at Baylor and Yale and directs their National Institute of Health (NIH) Medications Development Center for substance abuse. A recognized leader in clinical and translational sciences, Dr. Kosten is a past recipient of a NIH Research Scientist Award (1987-2010). He has served on national and international review groups for medications and vaccines development in substance abuse, and is credited with the development of several cutting-edge discoveries in medications for addictions.Dr. Kosten’s recent work includes serving on the National Academy of Sciences, Institute of Medicine (IOM) Committee on Vaccines for Substance Abuse. He also served on the recently concluded IOM’s Committee on Prevention, Diagnosis, Treatment, and Management of Substance Use Disorders in the US Armed Forces, a congressional mandate via the National Defense Authorization Act for Fiscal Year 2010 (Public Law 111-84) to conduct an independent study on substance use disorders in the military. Additionally, he continues to serve on various US Food and Drug Administration panels for medication approvals in psychiatry and analgesics.

 
Research Interest

Developing medications & vaccines for addictions
Pharmacology

Global Experts in the subject
Adriana Campa Ahmed Haque Bhopesh Thakur
Bruce Davies Carlos J. Rubinstein Deena J Tampi
Dikotlana Study Team Glennon W Simmons Herman Bussmann
J Bryan Page Jenna D. Moore-Liester John T McDevitt
Jorge Wong Joseph Makhema Julien S. Baker
L Cecil Powell Lesedi Tsalaile Manju Kaundal
Marianna K Baum Michael P McRae Michael R. Graham
Mitchell B Liester Moyo Sikhulele Myron Essex
Nicolaos Christodoulides O’Dale Williams Patricia Burns
R Constance Wiener Rajesh R Tampi Rhonda Conerly Holliday
Richard De La Garzall Richard Marlink Sabrina Sales Martinez
Shenghan Lai Silpa Chandran Silvia Fare
Sujan Barua Thomas F Newton Torrance Stephens
Yinghui Li Erik van Widenfelt
 
https://wowcappadocia.com
https://cappadocia-hotels.com
https://caruscappadocia.com
https://brothersballoon.com
https://balloon-rides.net

https://paperio-live.com

rolex replica

https://agario.red

https://naughtyworms.com

melbet
https://sekillinickyazi.com/